logo-loader
viewAgilent Technologies

Agilent Technologies shares fall after mixed fiscal second-quarter results

The Hewlett-Packard spin-off had one of the largest IPOs of its time

Medical labs
Shares fell in early Tuesday trading

Agilent Technologies Inc (NYSE:A) announced lukewarm fiscal second-quarter results, reporting earnings in line with expectations while revenue and guidance fell short.

The medical device company reported earnings of US$0.65 per share on revenue of US$1.21bn compared with US$0.58 EPS on revenue of US$1.1bn in the previous year’s first quarter.

The Silicon Valley company was in line with Wall Street estimates of $0.65 EPS, but its revenue of US$1.206bn was slightly below the consensus estimate of US$1.209bn.

Shares of the California-based company were down more than 10% to US$62.13 in early Tuesday trading.

Agilent is a spin-off of Hewlett-Packard Company (NYSE:HPQ) and its initial public offering in 1999 was one of the largest at the time, raising US$2.1bn.

READ: VolitionRx boosts cash reserves in 1Q, inks distribution deal with Active Motif

The company reaffirmed its full-year guidance, expecting fiscal third-quarter earnings between US$0.61 and US$0.63 on revenues between US$1.19bn and US$1.21bn. The outlook fell slightly below consensus estimates of US$0.65 EPS on revenue of US$1.21bn.

“We saw strength in the Pharma and Chemical & Energy markets with 8% and 5% growth this quarter, respectively,” said CEO Mike McMullen.

Agilent recently completed its acquisition of Genohm, a Swiss cloud-based software company, for an undisclosed amount.

Quick facts: Agilent Technologies

Price: 83.42 USD

NYSE:A
Market: NYSE
Market Cap: $25.78 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Cap-XX to acquire Murata’s supercapacitor production lines and relocate them...

Cap-XX Limited (LON:CPX) managing director, chief executive officer and founder Anthony Kongats updates Proactive on the company’s acquisition of Murata’s supercapacitor production lines which will be relocated from Japan to a new larger factory in Sydney. Cap-XX develops, manufactures and...

25 minutes ago

2 min read